Lao People's Democratic Republic
Tuberculosis profile
Population  2012 6.6 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.72 (0.43–1.1) 11 (6.5–16)
Mortality (HIV+TB only) 0.13 (0.11–0.24) 2 (1.6–3.6)
Prevalence  (includes HIV+TB) 34 (22–48) 514 (335–729)
Incidence  (includes HIV+TB) 14 (8.4–20) 204 (126–301)
Incidence (HIV+TB only) 0.25 (0.13–0.41) 3.8 (2–6.2)
Case detection, all forms (%) 30 (21–49)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 3 062 (79) Relapse 168 (82)
Smear-negative 484 (12) Treatment after failure 18 (9)
Smear-unknown / not done     Treatment after default 20 (10)
Extrapulmonary 351 (9) Other    
Other          
Total new 3 897   Total retreatment 206  
           
Other (history unknown) 53        
Total new and relapse 4 065   Total cases notified 4 156  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.6 1.6 1.2
Age < 15 21 21 25
Laboratories 2012
Smear (per 100 000 population) 2.4
Culture (per 5 million population) 2.3
Drug susceptibility testing (per 5 million population) 0.8
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 92   Is rifampicin used
throughout treatment for
new patients?
No
New smear-negative/extrapulmonary 82  
Retreatment 81  
TB/HIV 2012 Number (%)
TB patients with known HIV status 1 999 (48)
HIV-positive TB patients 234 (12)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 182 (78)
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB 3 645  
HIV-positive people provided with IPT 303  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4.9 (3.6–6.1) 23 (20–27)
MDR-TB cases among notified pulmonary
TB cases
170 (130–220) 48 (40–56)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 14 (<1%) 48 (23%) 62
Laboratory-confirmed MDR-TB cases 0 10 10
Patients started on MDR-TB treatment     9
Financing TB control 2013
National TB programme budget (US$ millions) 4.1
% Funded domestically  
% Funded internationally 100%
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data